HANTAVIRUS - ANVISA Registration 10338930257

Access comprehensive regulatory information for HANTAVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10338930257 and manufactured by EUROIMMUN AG. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until Aug 23, 2031.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 4 companies making the same product including Fundação Oswaldo Cruz - Instituto de Tecnologia em Imunobiológicos -, NOVATEC IMMUNDIAGNOSTICA GMBH TECHNOLOGIE & WALDPARK, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
4 Competitors
10338930257
2 Related Devices
Registration Details
ANVISA Registration Number: 10338930257
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Anti-Hanta Virus Pool 2 “America” ELISA (IgG)
Risk Class III

Registration Details

10338930257

25351623849202130

93741726000166

Company Information

EUROIMMUN AG
Germany
PT: ALEMANHA

Dates and Status

Aug 23, 2021

23/08/2031

09/18/2025 19:00:01

Anti-Hanta Virus Pool 2 “America” ELISA (IgG)
Risk Class III

Registration Details

10338930257

25351623849202130

93741726000166

Company Information

Dates and Status

Aug 23, 2021

23/08/2031

09/18/2025 19:00:01